Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform Blog Post
Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October 5, 2023— Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation software, today announced the…
Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model Blog Post
Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023 Sep 1;13(1):1434
Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug Blog Post
Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development programs can cause sponsors to have significant issues during the review period or impact the…
Certara Launches CoAuthor, a Regulatory and Medical Writing Tool Blog Post
Using AI to gain efficiencies for medical writers PRINCETON, N. J.— October 3, 2023— Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation software and advanced drug development solutions, today…
Accelerating a drug launch with value communication technology and an integrated workflow Blog Post
With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical company was presented with an opportunity for an accelerated market launch. The team faced several...
Medical Device | Medtronic Demonstrating the economic value of minimally invasive spinal surgery on the iPad Blog Post
This case study describes the use of a web-based platform to demonstrate the value of minimally invasive surgery on the iPad.
Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole) Blog Post
Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular, the time-consuming process of updating or modifying tools using custom app vendors would cause significant...
Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma Blog Post
In a sector where both competition and stakeholder expectations are high, a comprehensive approach that blends digital stakeholder engagement with effective value communication is crucial for success. This presentation offers…
Developing Pediatric PBPK Models for Differing Ethnic Populations Blog Post
Physiologically-based pharmacokinetic (PBPK) modeling has proven invaluable in drug development, especially for pediatric populations, because of its ability to reduce and potentially eliminate the need to conduct clinical trials in…
